AI assistant
iBio, Inc. — Director's Dealing 2011
Apr 14, 2011
35045_dirs_2011-04-14_07b62ed2-2689-44b9-8b99-6af82c6bcd91.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: iBio, Inc. (IBIO)
CIK: 0001420720
Period of Report: 2011-04-12
Reporting Person: KAY E GERALD (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-04-12 | Common Stock | S | 250000 | $0.50 | Disposed | 6136595 | Indirect |
Footnotes
F1: Shares sold in a private transaction pursuant to a Stock Option Agreement originally entered into on May 21, 2010 with Kobus Investments, LLC and Biomed Investments, LLC, as described in detail in the Issuer's Registration Statement on Form S-3 filed with the SEC on March 14, 2011.
F2: Includes (i) 819,629 shares of common stock held by EGK LLC, of which the reporting person is the manager and (ii) 1,266,706 shares of common stock owned by Integrated BioPharma, Inc. of which the reporting person is a member of a control group. Shares dispositive power with Christina Kay with respect to 169,358 shares of common stock and with Riva Kay Sheppard with respect to 169,358 shares of common stock.